Annual report pursuant to Section 13 and 15(d)

STOCK-BASED COMPENSATION (Tables)

v2.4.1.9
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2014
STOCK BASED COMPENSATION  
Schedule of stock-based compensation expense related to all of the entity's stock-based awards

        Total stock-based compensation expense related to all of our stock-based awards was as follows (in thousands):

                                                                                                                                                                                    

 

 

Year Ended December 31,

 

 

 

2014

 

2013

 

2012

 

Research and development

 

$

4,674 

 

$

3,930 

 

$

7,050 

 

General and administrative

 

 

5,113 

 

 

2,997 

 

 

5,567 

 

Restructuring charges

 

 

 

 

239 

 

 

—  

 

​  

​  

​  

​  

​  

​  

Total stock-based compensation expense

 

$

9,787 

 

$

7,166 

 

$

12,617 

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

 

Summary of weighted-average assumptions relating to options granted pursuant to equity incentive plans

                                                                                                                                                                                    

 

 

Equity Incentive
Plans

 

 

 

Year Ended
December 31,

 

 

 

2014

 

2013

 

2012

 

Risk-free interest rate

 

 

2.2 

%

 

1.1 

%

 

0.9 

%

Expected term (in years)

 

 

6.5 

 

 

5.4 

 

 

5.5 

 

Dividend yield

 

 

0.0 

%

 

0.0 

%

 

0.0 

%

Expected volatility

 

 

74.4 

%

 

72.2 

%

 

81.5 

%

 

Schedule of option activity under equity incentive plans

                                                                                                                                                                                    

 

 

Shares
Available
For Grant

 

Number of
Shares
Underlying
Options

 

Weighted-
Average
Exercise Price

 

Weighted-
Average
Remaining
Contractual
Term
(in years)

 

Aggregate
Intrinsic
Value

 

Outstanding at January 1, 2012

 

 

4,707,753

 

 

11,749,359

 

$

12.07

 

 

 

 

 

 

 

​  

​  

​  

​  

Authorized for grant

 

 

600,000

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

(2,149,266

)

 

2,149,266

 

$

8.13

 

 

 

 

 

 

 

Exercised

 

 

 

 

(254,149

)

$

7.08

 

 

 

 

 

 

 

Cancelled

 

 

40,099

 

 

(40,099

)

$

19.60

 

 

 

 

 

 

 

​  

​  

​  

​  

Outstanding at December 31, 2012

 

 

3,198,586

 

 

13,604,377

 

$

11.52

 

 

 

 

 

 

 

​  

​  

​  

​  

Authorized for grant

 

 

7,775,000

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

(3,140,956

)

 

3,140,956

 

$

5.46

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

$

 

 

 

 

 

 

 

Cancelled

 

 

1,213,131

 

 

(1,213,131

)

$

8.26

 

 

 

 

 

 

 

​  

​  

​  

​  

Outstanding at December 31, 2013

 

 

9,045,761

 

 

15,532,202

 

$

10.55

 

 

 

 

 

 

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

Authorized for grant

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

(3,467,120

)

 

3,467,120

 

$

3.39

 

 

 

 

 

 

 

Exercised

 

 

 

 

(11,219

)

$

3.44

 

 

 

 

 

 

 

Cancelled

 

 

2,017,430

 

 

(2,017,430

)

$

10.75

 

 

 

 

 

 

 

​  

​  

​  

​  

Outstanding at December 31, 2014

 

 

7,596,071

 

 

16,970,673

 

$

9.07

 

 

5.79

 

$

25,140

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

Vested and expected to vest at December 31, 2014

 

 

 

 

 

16,861,378

 

$

9.10

 

 

 

 

 

 

 

​  

​  

​  

​  

​  

Exercisable at December 31, 2014

 

 

 

 

 

14,243,893

 

$

10.09

 

 

5.19

 

$

983

 

​  

​  

​  

​  

​  

Exercisable at December 31, 2013

 

 

 

 

 

13,246,612

 

$

11.44

 

 

 

 

 

 

 

​  

​  

​  

​  

​  

Exercisable at December 31, 2012

 

 

 

 

 

12,841,378

 

$

11.75

 

 

 

 

 

 

 

​  

​  

​  

​  

​  

 

Schedule of stock options by exercise price

        Details of our stock options by exercise price are as follows as of December 31, 2014:

                                                                                                                                                                                    

 

 

Options Outstanding

 

Options Exercisable

 

Exercise Price

 

Number of
Outstanding
Options

 

Weighted-
Average
Remaining
Contractual
Life
(in years)

 

Weighted-
Average
Exercise
Price

 

Number of
Options

 

Weighted-
Average
Exercise
Price

 

$1.68 - $3.55

 

 

2,317,779 

 

 

8.77 

 

$

3.29 

 

 

1,112,849 

 

$

3.36 

 

$3.59 - $6.49

 

 

3,300,357 

 

 

6.80 

 

 

4.99 

 

 

2,050,668 

 

 

5.84 

 

$6.51 - $6.55

 

 

2,207,938 

 

 

7.53 

 

 

6.52 

 

 

1,991,664 

 

 

6.52 

 

$6.73 - $7.40

 

 

2,196,855 

 

 

5.32 

 

 

6.85 

 

 

2,187,713 

 

 

6.85 

 

$7.53 - $8.27

 

 

2,132,765 

 

 

6.42 

 

 

8.11 

 

 

2,091,925 

 

 

8.11 

 

$8.34 - $11.73

 

 

2,528,537 

 

 

3.52 

 

 

10.29 

 

 

2,522,633 

 

 

10.29 

 

$15.49 - $24.56

 

 

1,132,244 

 

 

0.96 

 

 

23.41 

 

 

1,132,244 

 

 

23.41 

 

$26.45

 

 

1,154,198 

 

 

3.08 

 

 

26.45 

 

 

1,154,198 

 

 

26.45 

 

​  

​  

​  

​  

$1.68 - $26.45

 

 

16,970,673 

 

 

5.79 

 

 

9.07 

 

 

14,243,894 

 

$

10.09 

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

 

Summary of weighted-average assumptions used to calculate fair value of purchase rights granted under Employee Stock Purchase Plan

 

 

Employee Stock
Purchase Plan

 

 

 

Year Ended
December 31,

 

 

 

2014

 

2013

 

2012

 

Risk-free interest rate

 

 

0.3 

%

 

0.2 

%

 

0.2 

%

Expected term (in years)

 

 

1.7 

 

 

1.4 

 

 

1.2 

 

Dividend yield

 

 

0.0 

%

 

0.0 

%

 

0.0 

%

Expected volatility

 

 

66.0 

%

 

64.4 

%

 

47.4 

%